CD8+ CD28− regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2024-07, Vol.38 (7), p.1621-1625
Hauptverfasser:	Kriegsmann, Katharina, Ton, Gigi Nu Hoang Quy, Awwad, Mohamed H. S., Benner, Axel, Bertsch, Uta, Besemer, Britta, Hänel, Mathias, Fenk, Roland, Munder, Markus, Dürig, Jan, Blau, Igor W., Huhn, Stefanie, Hose, Dirk, Jauch, Anna, Mann, Christoph, Weinhold, Niels, Scheid, Christof, Schroers, Roland, von Metzler, Ivana, Schieferdecker, Aneta, Thomalla, Jörg, Reimer, Peter, Mahlberg, Rolf, Graeven, Ullrich, Kremers, Stephan, Martens, Uwe M., Kunz, Christian, Hensel, Manfred, Seidel-Glätzer, Andrea, Weisel, Katja C., Salwender, Hans J., Müller-Tidow, Carsten, Raab, Marc S., Goldschmidt, Hartmut, Mai, Elias K., Hundemer, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	13/31 38/32 45 631/67/1990/804 692/308/2779/109/1942 Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Research CD28 antigen CD28 Antigens CD8 antigen CD8-Positive T-Lymphocytes - immunology Clinical trials Critical Care Medicine Hematology Hospitals Humans Immunology Immunoregulation Induction Chemotherapy Induction therapy Intensive Internal Medicine Letter Leukemia Lymphocytes Lymphocytes T Male Medicine Medicine & Public Health Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - immunology Multiple Myeloma - mortality Multiple Myeloma - pathology Myeloma Oncology Prognosis Progression-Free Survival Stem cell transplantation Survival Rate T-Lymphocytes, Regulatory - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0887-6924 1476-5551 1476-5551
DOI:	10.1038/s41375-024-02290-y